Gene · 2235
Papers1,987
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 1,987
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Crosstalk between regulated necrosis and micronutrition, bridged by reactive oxygen species. | Front Nutr | 2022 | 36211509 | PubTator, text mining | PubMed |
| Effect of a 5-aminolevulinic acid gel and 660 nm red LED light on human oral osteoblasts: a preliminary in vitro study. | Lasers Med Sci | 2022 | 36192667 | PubTator, text mining | PubMed |
| The impact of heme biosynthesis regulation on glioma aggressiveness: Correlations with diagnostic molecular markers. | Front Mol Neurosci | 2022 | 36187350 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis for novel miRNAs markers and ceRNA network in diabetic retinopathy. | Front Genet | 2022 | 36186470 | PubTator, text mining | PubMed |
| Non-occupational lead poisoning associated with traditional Chinese medicine: A case report. | Front Public Health | 2022 | 36176514 | PubTator, text mining | PubMed |
| Iron Metabolism in the Disorders of Heme Biosynthesis. | Metabolites | 2022 | 36144223 | PubTator, text mining | PubMed |
| Causes and Pathophysiology of Acquired Sideroblastic Anemia. | Genes (Basel) | 2022 | 36140729 | PubTator, text mining | PubMed |
| Safe surgery for glioblastoma: Recent advances and modern challenges. | Neurooncol Pract | 2022 | 36127890 | PubTator, text mining | PubMed |
| A Randomized Phase 2 Study of 5-Aminolevulinic Acid Hydrochloride and Sodium Ferrous Citrate for the Prevention of Nephrotoxicity Induced by Cisplatin-Based Chemotherapy of Lung Cancer. | Oncology | 2022 | 36099876 | PubTator, text mining | PubMed |
| Emerging concepts in cancer therapy: Mechanisms of resistance. | Cancer Rep (Hoboken) | 2022 | 36083019 | PubTator, text mining | PubMed |
| 5‑Aminolevurinic acid inhibits the proliferation of bladder cancer cells by activating heme synthesis. | Oncol Rep | 2022 | 36082808 | PubTator, text mining | PubMed |
| LACTB, a Metabolic Therapeutic Target in Clinical Cancer Application. | Cells | 2022 | 36078157 | PubTator, text mining | PubMed |
| An Update on Photodynamic Therapy of Psoriasis-Current Strategies and Nanotechnology as a Future Perspective. | Int J Mol Sci | 2022 | 36077239 | PubTator, text mining | PubMed |
| FECH Expression Correlates with the Prognosis and Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma. | J Oncol | 2022 | 36059798 | PubTator, text mining | PubMed |
| Exploring the mechanistic link between SF3B1 mutation and ring sideroblast formation in myelodysplastic syndrome. | Sci Rep | 2022 | 36028755 | PubTator, text mining | PubMed |
| Combination-Based Strategies for the Treatment of Actinic Keratoses with Photodynamic Therapy: An Evidence-Based Review. | Pharmaceutics | 2022 | 36015352 | PubTator, text mining | PubMed |
| 5-ALA Is a Potent Lactate Dehydrogenase Inhibitor but Not a Substrate: Implications for Cell Glycolysis and New Avenues in 5-ALA-Mediated Anticancer Action. | Cancers (Basel) | 2022 | 36010996 | PubTator, text mining | PubMed |
| An Anticancer Rhenium Tricarbonyl Targets Fe-S Cluster Biogenesis in Ovarian Cancer Cells. | Angew Chem Int Ed Engl | 2022 | 36004624 | PubTator, text mining | PubMed |
| Effect of Roxadustat on Factors Associated with Renal Fibrosis and Efficacy. | Comput Math Methods Med | 2022 | 35979053 | PubTator, text mining | PubMed |
| Genomes from Uncultivated Pelagiphages Reveal Multiple Phylogenetic Clades Exhibiting Extensive Auxiliary Metabolic Genes and Cross-Family Multigene Transfers. | mSystems | 2022 | 35972150 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2235/papers?page=16